Business Context and Reporting Period
This Form 8-K is filed by Aziyo Biologics, Inc. (trading symbol: AZYO) on October 9, 2022. The report details an amendment to a material definitive agreement regarding the company's credit facility.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, or margin data. It focuses on debt and liquidity covenants:
- Total Credit Facility: $25 million in senior secured term loans (originally entered August 10, 2022).
- Contingent Availability: $4 million of the facility is subject to achieving specified operational and financial metrics by September 30, 2023.
- Minimum Liquidity Requirement: $5.0 million (extended deadline).
Material Changes
The primary material change is the execution of an Amendment Letter on October 9, 2022, which modified the terms of the existing Credit Agreement:
- Liquidity Step-Up Date Extension: The date by which the company must meet minimum liquidity requirements was extended from October 10, 2022, to November 10, 2022.
- Revised Liquidity Covenant: The company must maintain minimum liquidity of $5.0 million until November 10, 2022. Thereafter, the requirement is the greater of $5.0 million or the sum of the Operating Burn for the two prior consecutive fiscal quarters.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond the implications of the amended credit agreement. The amendment indicates a need for additional time to meet liquidity thresholds, suggesting potential short-term liquidity management challenges.
Investor Verification Checklist
- Verify the company's current cash balance to ensure compliance with the $5.0 million minimum liquidity requirement through November 10, 2022.
- Review the definition of "Operating Burn" in the Credit Agreement to understand future liquidity covenant calculations.
- Monitor progress toward the operational and financial metrics required to unlock the $4 million contingent portion of the credit facility by September 30, 2023.
- Confirm the status of the $25 million senior secured term loan and any associated interest or repayment schedules.